Skip to main content
. 2020 Jun 19;15(1):1783048. doi: 10.1080/19932820.2020.1783048

Table 5.

Impact of Hib vaccine on admissions and in-hospital deaths related to respiratory infections among children aged under 3 years old.

    Cases Population Absolute risk * (95% CI) ARR* Relative risk (95% CI) RRR (95% CI) NNT P
Hib Pneumonia        
Protocol 1 Vaccinated 121 1121344 10.7 (8.86; 12.71) 0.84 0.92 (0.74;1.15)     0.492
Unvaccinated 261 2242688 11.6 (10.2; 13.0)
Protocol 2 Vaccinated 9 1121344 0.80 (0.027; 1.30) 10.83 0.068 (0.035;0.13) 0.99 (0.94;0.99) 9230 (7773;11359) < 0.0001
Unvaccinated 261 2242688 8.17 (7.31;9.03)
Acute otitis media                
Protocol 1 Vaccinated 11 1121344 0.98 (0.40;1.56) 0.49 0.66 (0.33;1.32)     0.24
Unvaccinated 33 2242688 1.47 (0.96;1.97)
Protocol 2 Vaccinated 5 1121344 0.44 (0.05;0.84) 1.02 0.30 (0.11;0.77) 0.69 (0.22;0.88) 9751 (55946;379283) 0.012
Unvaccinated 33 2242688 1.47 (0.96;1.97)
Deaths all causes aged <3 years                
Protocol 1 Vaccinated 2 1121344 0.17 (0.06;0.43) 0.83 0.16 (0.04,0.70) 0.83 (0.29;0.96) 112135 (65703;382310) 0.0149
Unvaccinated 24 2242688 1.07 (0.64; 1.49)
Protocol 2 Vaccinated 0 1121344 0 1.07 0.0408 (0.002;0.67) 0.99 95434 (60030;232629) 0.0252
Unvaccinated 24 2242688 1.07 (0.64; 1.49)

*: per 100,000 inh; unvaccinated cohort: patients born between 2005 and 2011; vaccinated by protocol 1: patients born between 2002 and 2005, with Hib monovalent vaccine at 3, 4, 6 months; vaccinated by protocol 2: patients born after 2011, with a Hib pentavalent combination vaccine at 2, 3 and 6 months; ARR: Absolute Risk Reduction; RRR: relative risk reduction; NNT: Number Needed to Treat